Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Incyte Corporation INCY

Healthcare  —  Biotechnology
123.36 (1.46) (1.17%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Incyte Corporation (INCY) Current ratio

Incyte Corporation's current ratio at the end of the quarter to 30 June 2026 was 4.6×, up 1.3× from fiscal 2025 (3.3×). Over the past ten years it has ranged from 2.0× (fiscal 2024) to 5.0× (fiscal 2015); the current reading is higher than 18% of that period. That is in line with the Biotechnology industry median of 4.7× and above the Healthcare sector median of 3.0×.

Current ratio, annual

Annual

Period Current ratio Change
FY2025 3.3× 68.07%
FY2024 2.0× (47.32%)
FY2023 3.7× 5.88%
FY2022 3.5× (3.10%)
FY2021 3.7× (2.36%)
FY2020 3.7× (22.66%)
FY2019 4.8× 12.20%
FY2018 4.3× 7.48%
FY2017 4.0× 10.28%
FY2016 3.6× (27.50%)

Quarterly

Period Current ratio Change
Jun 2026 4.6× 24.76%
Mar 2026 3.7× 11.04%
Dec 2025 3.3× 3.76%
Sep 2025 3.2× 12.13%
42 more quarters

Against its own ten years

Low 2.0× High 5.0×
Ten-year median 3.7×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
ROIV Roivant Sciences Ltd. compare 16.7×
BNTX BioNTech SE Sponsored ADR compare 7.8×
INCY Incyte Corporation 4.6×
INSM Insmed, Inc. compare 3.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 3.4×
ALNY Alnylam Pharmaceuticals, Inc. compare 3.1×
RPRX Royalty Pharma PLC compare 2.8×
GMAB Genmab A/S Sponsored ADR compare 2.5×
JAZZ Jazz Pharmaceuticals PLC compare 1.8×
Biotechnology industry median 4.7×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on INCY